Medications
Editorial: Lurbinectedin for neuroendocrine tumors
A new editorial paper was published in Oncoscience, titled "Lurbinectedin, a DNA minor groove inhibitor for neuroendocrine neoplasms beyond small cell lung cancer."
Oct 6, 2023
0
47
Page 2 - News tagged with neuroendocrine cells
Oncology & Cancer
Study defines a possible target for future treatments for a deadly form of the disease
Scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have discovered that a protein produced by a cancer gene leads to the development of a deadly, late-stage form of prostate ...
Apr 1, 2016
0
6
Medical research
Excess neuropeptides disrupt lung function in infant disease and COVID-19
COVID-19 has put a spotlight on the pulmonary and nervous systems, but there is still much to learn about how they interact. Researchers at University of California San Diego School of Medicine recently explored this relationship ...
Mar 18, 2022
0
21
Oncology & Cancer
Study provides new look at why rare cancer often evades treatments
Researchers at Boston Medical Center and Dana-Farber Cancer Institute have conducted one of the first-ever analyses of neuroendocrine tumors (NETs) at single-cell resolution, unlocking new insights into this rare and often ...
Sep 28, 2023
0
18
Oncology & Cancer
Dual-action drug produces positive results in patients with advanced neuroendocrine tumors, trial finds
A drug that simultaneously strikes cancer cells' growth circuits and pipeline to the bloodstream produced encouraging results in a clinical trial involving patients with advanced neuroendocrine tumors, according to a study ...
Oct 22, 2023
0
0
Oncology & Cancer
Neuronal molecule makes prostate cancer more aggressive
Prostate cancer is the second most common cancer and the second leading cause of cancer death among American men. Now, researchers have discovered key molecular players that drive prostate cancer to progress into a highly ...
Jan 24, 2023
0
29
Oncology & Cancer
Radiopeptide therapy improves survival outcomes for neuroendocrine cancer patients
Peptide-receptor radionuclide therapy (PRRT) has been a subject of growing research on neuroendocrine tumors, which take up residence in a variety of organs replete with nerve cells that respond to hormone signaling. A countrywide ...
Jun 11, 2013
0
3
Medical research
Small cell lung cancer: Scientists identify two new approaches for therapy
Using samples of small cell lung tumors, a research team led by biologist Dr. Silvia von Karstedt has discovered two new ways to induce tumor cell death. One of two subsets of tumor cells can be targeted by activating ferroptosis: ...
Apr 6, 2021
0
75
Oncology & Cancer
Researchers discover Achilles' heel in lethal form of prostate cancer
An international team of researchers led by clinicians at Weill Cornell Medical College have discovered a genetic Achilles' heel in an aggressive type of prostate cancer -- a vulnerability they say can be attacked by a targeted ...
Nov 17, 2011
1
0
Oncology & Cancer
CAR T cells suppress GI solid tumor cells, without toxicity to healthy tissue, in preclinical research
Chimeric antigen receptor (CAR) T cells can be remarkably effective in treating leukemias and lymphomas, but there are no successful immunotherapies for neuroendocrine tumors (NETs) and gastrointestinal cancers (GICs) yet. ...
Mar 24, 2022
0
47
